Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-03-02 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document text is a formal announcement dated March 2, 2012, detailing share transactions conducted by senior management ('Koncerndirektør') on March 1, 2012. The table explicitly lists the 'Relation/category of closely related party', 'Transaction character' (Salg af aktier - Sale of shares), and the size/value of the transaction. This content directly corresponds to the definition of Director's Dealing or insider trade reports, which is classified as 'DIRS' (Director's Dealing). The document structure and content are typical of mandatory regulatory disclosures regarding insider transactions.
2012-03-02 English
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document explicitly reports transactions made by company executives (EVP, Stakeholder Relations; EVP BioBusiness) involving the sale of shares on specific dates (29/2/2012). This directly corresponds to the definition of Director's Dealing, which covers personal share transactions by company directors and executives (insider trades). The filing category DIRS (Director's Dealing) is the most appropriate classification.
2012-03-01 English
Regulatory Filings 2012
Regulatory Filings
2012-03-01 Danish
AGM Information 2012
AGM Information Classification · 98% confidence The document text explicitly mentions that 'Novozymes A/S yesterday held its Annual Shareholders' Meeting' and that certain items 'were approved'. This content directly relates to the proceedings and outcomes of the Annual General Meeting (AGM). Although it is a very short announcement prompting the user to 'Read the whole announcement', the core subject matter is the AGM itself, making AGM-R the most appropriate classification over a general RPA or RNS, as the content is specific to the meeting's results/approvals.
2012-03-01 English
AGM Information 2012
AGM Information Classification · 98% confidence The document text is extremely short (109 characters) and is written in Danish. The key phrase is "Novozymes A/S afholdt i går ordinær generalforsamling, hvor følgende blev godkendt: Læs hele meddelelsen" which translates to "Novozymes A/S held its annual general meeting yesterday, where the following was approved: Read the full announcement". This indicates that the document is an announcement *about* the Annual General Meeting (AGM) and directs the reader to read the full details elsewhere. Since it is an announcement related to the AGM, and not the detailed presentation materials themselves, the most appropriate classification is AGM Information (AGM-R), as it directly relates to the meeting proceedings.
2012-03-01 Danish
Regulatory Filings 2012
Regulatory Filings
2012-02-29 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.